Received Apr 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | Y006122 | OT |
No additional AE/PQC; HCP called to ask if a 19 year old patient received a pediatric dose of VAQTA will it be counted as valid or they should restart the adult vaccine The dose was administered on 03/12/2025. No symptoms reported. Consent was provided to follow up with; This spontaneous report was received from a licensed practiced nurse (LPN) via a company representative referring to a 19-year-old patient of unknown gender. The patient's medical history, historical drugs, past drug reactions or allergies, concurrent conditions, and concomitant drugs were not reported. On 12-MAR-2025, the patient was vaccinated with a pediatric dose of Hepatitis A Vaccine, Inactivated (VAQTA) 25/0.5 (0.5 ml once, lot#: y006122, expiration date: 17-MAY-2025) via route of intramuscular (IM) for prophylaxis by a healthcare professional (underdose). No additional adverse events were reported (no adverse event).